bioecon Member area

fermentation & cell culture — Recombinant human serum albumin (rHSA)

Recombinant human serum albumin (rHSA) replaces plasma-derived HSA (pHSA) — constrained by donor blood supply and viral-contamination risk since the 1940s — with the first FDA/EMA/PMDA-approved rice-derived rHSA for injection.

Price on requestSupplier sourcingpaid serviceMaturity 5/9updated in the shop 2026-10-18
Upstream — fermentation & cell culture

How it works

This is a procurement category, not a named manufacturer's product. As a paid service, Bioecon finds suppliers for your task, agrees configuration and specification, and arranges supply; the price is on request. Bioecon may receive a fee from suppliers — this is disclosed and does not affect the portal's grades or lists.

Services and how they fund the open data →

Technology

Recombinant human serum albumin (rHSA) — Evidence, registration route, funding and suppliers are on the technology page.

Recombinant human serum albumin (rHSA) replaces plasma-derived HSA (pHSA) — constrained by donor blood supply and viral contamination risk since the 1940s — with biosynthetic production in yeast (Pichia pastoris, Hansenula polymorpha) or plant (rice endosperm) hosts: Healthgen Biotech's OsrHSA (奥福民 …

Pharma & biologics

Links

Related items